The RACE team has just kicked another goal, a big one. With the granting of Allowance for Bisantrene Patent in the USA, the company has just made its key asset hugely more valuable. When ‘full’ status is granted, the company is clear in the US (world’s biggest pharma market) until 2034 !!!
This board just keeps ticking boxes. Very impressive.
First ‘named-patient’ sales will commence soon bringing an excellent income stream.
What next? A TargImmune breakthrough? A big pharma deal? A take-over?
So few shares available. So much potential. Love it.
My opinion only, of course.
Ann: Notice of Allowance for Bisantrene Patent in US, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
-0.025(1.47%) |
Mkt cap ! $282.9M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.66 | $43.87K | 26.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 130 | $1.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 882 | 2 |
View Market Depth
| Last trade - 11.21am 18/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |